Investing Profile

Issi Rozen

VCInvestor
General Partner at GV (Google Ventures)
gv.com/team/issi-rozen/Cambridge, Massachusetts
Photo of Issi Rozen, General Partner at GV (Google Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
GV (Google Ventures) Network
16 CONNECTIONS
GV (Google Ventures) Network
16 CONNECTIONS
Broad Institute of MIT and Harvard Network
11 CONNECTIONS
Broad Institute of MIT and Harvard Network
11 CONNECTIONS
cb
GV (Google Ventures) General Partner
$250K - $50.0M
$25.0M
8
$8B
CompanyStageDateRound SizeTotal Raised
Mestag Therapeutics
Series UnknownMar 2026$40M
$40M
Co-investors: David Schenkein (GV (Google Ventures))
nChroma Bio
Series UnknownDec 2024$75M
$75M
Chroma Medicine
Series BFeb 2023$140M
$140M
Aera Therapeutics
Series BFeb 2023$190M
Series AFeb 2023
$190M
Co-investors: David Schenkein (GV (Google Ventures)), Robert Nelsen (ARCH Venture Partners)
Monte Rosa Therapeutics
Series CMar 2021$95M
Series BSep 2020$96M
$220M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), David Schenkein (GV (Google Ventures)), Andrew Schiff (Aisling Capital), Chandra Leo (HBM Partners AG)
EveryONE Medicines
SeedJan 2020
Co-investors: Anthony Philippakis (GV (Google Ventures))
General Partner GV (Google Ventures)2023 - Present
Member Board of Directors Institute for Protein Innovation2023 - Present
Member Board Of Directors Mestag Therapeutics2021 - Present
Co-Founder Verve Therapeutics2018 - Present
Venture Partner GV (Google Ventures)2019 - 2023
Member Board of Directors Sherlock Biosciences2019 - 2022
Member Board of Directors iZotope, Inc.2014 - 2021
Chief Business Officer Broad Institute of MIT and Harvard2016 - 2021
Co-Founder Multiple Biotech Companies2011 - 2020
Senior Director, Strategic Alliances Broad Institute of MIT and Harvard2011 - 2016